New Delhi Metallo-β-Lactamase–producing Enterobacteriaceae, United States
J. Kamile Rasheed , Brandon Kitchel, Wenming Zhu, Karen F. Anderson, Nancye C. Clark, Mary Jane Ferraro, Patrice Savard, Romney M. Humphries, Alexander J. Kallen, and Brandi M. Limbago
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.K. Rasheed, B. Kitchel, W. Zhu, K.F. Anderson, N.C. Clark, A.J. Kallen, B.M. Limbago); Massachusetts General Hospital, Boston, Massachusetts, USA (M.J. Ferraro); Johns Hopkins University, Baltimore, Maryland, USA (P. Savard); Johns Hopkins Health System, Baltimore (P. Savard); University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA (R.M. Humphries)
Figure 1. . XmnI restriction analysis of New Delhi metallo-β-lactamase (NDM)–encoding plasmids, United States, April 2009–March 2011, from transformants (A) and subsequent Southern blot analysis with digoxigenin-labeled blaNDM probe hybridized to a blot of same gel (B). Lane 1, NDM PCR product, positive control; lane 2, NDM-negative plasmid (ATCC-1705); lanes 3 and 14, 1-kb plus marker; lane 4, TF 0S-506; lane 5, TF 1100770; lane 6, TF 1100975; lane 7, TF1100192; lane 8, TF 1000527; lane 9, TF 1101459; lane 10, TF 1101168; lane 11, TF 1100101; lane 12, TF 1001728; lane 13, TF 1000654.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.